keyword
https://read.qxmd.com/read/38650175/kinase-activities-in-pancreatic-ductal-adenocarcinoma-with-prognostic-and-therapeutic-avenues
#1
JOURNAL ARTICLE
Andrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, Sander R Piersma, Thang V Pham, Jaco C Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R Jiménez, Maarten F Bijlsma
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited number of known driver mutations but considerable cancer cell heterogeneity. Phosphoproteomics provides a direct read-out of aberrant signaling and the resultant clinically relevant phenotype. Mass spectrometry (MS)-based proteomics and phosphoproteomics were applied to 42 PDAC tumors. Data encompassed over 19 936 phosphoserine or phosphothreonine (pS/T; in 5412 phosphoproteins) and 1208 phosphotyrosine (pY; in 501 phosphoproteins) sites and a total of 3756 proteins...
April 22, 2024: Molecular Oncology
https://read.qxmd.com/read/38646155/phosphoproteomic-analysis-identified-mutual-phosphorylation-of-fak-and-src-as-a-mechanism-of-osimertinib-resistance-in-egfr-mutant-lung-cancer
#2
JOURNAL ARTICLE
Takehiro Tozuka, Rintaro Noro, Keisuke Yoshida, Satoshi Takahashi, Mariko Hirao, Kuniko Matsuda, Yasuhiro Kato, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Akihiko Miyanaga, Shinobu Kunugi, Kazufumi Honda, Jun Adachi, Masahiro Seike
INTRODUCTION: Osimertinib is a standard treatment for patients with EGFR -mutant NSCLC. Although some osimertinib resistance mechanisms have been identified, nearly 50% of the mechanisms remain to be elucidated. This study was aimed at identifying non-genetic mechanisms underlying osimertinib resistance. METHODS: We established two osimertinib-resistant cell lines from EGFR mutation-positive PC-9 and HCC827 NSCLC cell lines (PC-9OR and HCC827OR, respectively) using a stepwise method...
April 2024: JTO clinical and research reports
https://read.qxmd.com/read/38645195/the-rac1-homolog-ced-10-is-a-component-of-the-mes-1-src-1-pathway-for-asymmetric-division-of-the-c-elegans-ems-blastomere
#3
Helen Lamb, Małgorzata Liro, Krista Myles, McKenzi Fernholz, Holly Anderson, Lesilee S Rose
Asymmetric cell division is essential for the creation of cell types with different identities and functions. The EMS blastomere of the four-cell Caenorhabditis elegans embryo undergoes an asymmetric division in response to partially redundant signaling pathways. One pathway involves a Wnt signal emanating from the neighboring P2 cell, while the other pathway is defined by the receptor-like MES-1 protein localized at the EMS/P2 cell contact, and the cytoplasmic kinase SRC-1. In response to these pathways, the EMS nuclear-centrosome complex rotates so that the spindle forms on the anterior-posterior axis; after division, the daughter cell contacting P2 becomes the endodermal precursor cell...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645030/inactivation-of-a-non-canonical-gp130-signaling-arm-attenuates-chronic-systemic-inflammation-and-multimorbidity-induced-by-a-high-fat-diet
#4
Youngjoo Lee, Arijita Sarkar, Jade Tassey, Jonathan N Levi, Siyoung Lee, Nancy Q Liu, Andrew C Drake, Jenny Magallanes, Una Stevic, Jinxiu Lu, Dawei Ge, Hanhan Tang, Tadiwanashe Mkaratigwa, Fangzhou Bian, Ruzanna Shkhyan, Michael Bonaguidi, Denis Evseenko
Interleukin-6 (IL-6) is a major pro-inflammatory cytokine for which the levels in plasma demonstrate a robust correlation with age and body mass index (BMI) as part of the senescence-associated secretory phenotype. IL-6 cytokines also play a crucial role in metabolic homeostasis and regenerative processes, primarily via the canonical STAT3 pathway. Thus, selective modulation of IL-6 signaling may offer a unique opportunity for therapeutic interventions. Recently, we discovered that a non-canonical signaling pathway downstream of tyrosine (Y) 814 within the intracellular domain of gp130, the IL-6 co-receptor, is responsible for the recruitment and activation of SRC family of kinases (SFK)...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38642796/egfr-inhibition-by-erlotinib-rescues-desmosome-ultrastructure-and-keratin-anchorage-and-protects-against-pemphigus-vulgaris-igg-induced-acantholysis-in-human-epidermis
#5
JOURNAL ARTICLE
Desalegn Tadesse Egu, Thomas Schmitt, Nancy Ernst, Ralf Joachim Ludwig, Michael Fuchs, Matthias Hiermaier, Sina Moztarzadeh, Carla Sebastià Morỏn, Enno Schmidt, Vivien Beyersdorfer, Volker Spindler, Letyfee Sarah Steinert, Franziska Vielmuth, Anna Magdalena Sigmund, Jens Waschke
Pemphigus is a severe blistering disease caused by autoantibodies primarily against the desmosomal cadherins desmoglein (DSG)1 and DSG3 which impair desmosome integrity. Especially for the acute phase, additional treatment options allowing to reduce corticosteroids would fulfill an unmet medical need. Here, we provide evidence that epidermal growth factor receptor (EGFR) inhibition by erlotinib ameliorates pemphigus vulgaris immunoglobulin G (PV-IgG) -induced acantholysis in intact human epidermis. PV-IgG caused phosphorylation of EGFR (Y845) and SRC in human epidermis...
April 18, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38640560/the-roles-of-sfks-in-the-regulation-of-proinflammatory-cytokines-and-nlrp3-in-familial-mediterranean-fever-patients
#6
JOURNAL ARTICLE
Irmak İçen Taşkın, Sevim Gürbüz, Ahmet Koç, Samet Kocabay, Servet Yolbaş, Muhammed Furkan Keser
Familial Mediterranean Fever (FMF) is caused by mutations in pyrin, a protein produced in innate immune cells that regulates the development of interleukin (IL)-1β by interacting with caspase-1 and other components of inflammasomes. Although overexpression of proinflammatory cytokines have been observed in FMF patients, no studies have been conducted on the role of Src family kinases (SFKs). The purpose of this study was to examine the impact of SFKs on the modulation of IL-1β, IL-6, IL-8, TNF-α, and NLRP3 inflammasome in patients with FMF...
April 18, 2024: Cytokine
https://read.qxmd.com/read/38639990/the-cd4-transmembrane-ggxxg-and-juxtamembrane-c-f-cv-c-motifs-mediate-pmhcii-specific-signaling-independently-of-cd4-lck-interactions
#7
JOURNAL ARTICLE
Mark S Lee, Peter J Tuohy, Caleb Y Kim, Philip P Yost, Katrina Lichauco, Heather L Parrish, Koenraad Van Doorslaer, Michael S Kuhns
CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al...
April 19, 2024: ELife
https://read.qxmd.com/read/38637878/enhancement-of-netosis-by-ace2-cross-reactive-anti-sars-cov-2-rbd-antibodies-in-patients-with-covid-19
#8
JOURNAL ARTICLE
Kun-Han Hsieh, Chiao-Hsuan Chao, Yi-Ling Cheng, Yen-Chung Lai, Yung-Chun Chuang, Jen-Ren Wang, Sui-Yuan Chang, Yuan-Pin Hung, Yi-Ming Arthur Chen, Wei-Lun Liu, Woei-Jer Chuang, Trai-Ming Yeh
BACKGROUND: High levels of neutrophil extracellular trap (NET) formation or NETosis and autoantibodies are related to poor prognosis and disease severity of COVID-19 patients. Human angiotensin-converting enzyme 2 (ACE2) cross-reactive anti-severe acute respiratory syndrome coronavirus 2 spike protein receptor-binding domain (SARS-CoV-2 RBD) antibodies (CR Abs) have been reported as one of the sources of anti-ACE2 autoantibodies. However, the pathological implications of CR Abs in NET formation remain unknown...
April 18, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38627210/proteome-based-molecular-subtyping-and-therapeutic-target-prediction-in-gastric-cancer
#9
JOURNAL ARTICLE
Changyuan Hu, Jiangning Song, Terry Kwok, Elizabeth V Nguyen, Xian Shen, Roger J Daly
Different molecular classifications for gastric cancer (GC) have been proposed based on multi-omics platforms with the long-term goal of improved precision treatment. However, the GC (phospho)proteome remains incompletely characterized, particularly at the level of tyrosine phosphorylation. In addition, previous multiomics-based stratification of patient cohorts has lacked identification of corresponding cell line models and comprehensive validation of broad or subgroup-selective therapeutic targets. To address these knowledge gaps, we applied a reverse approach, undertaking the most comprehensive (phospho)proteomic analysis of GC cell lines to date and cross-validating this using publicly available data...
April 16, 2024: Molecular Oncology
https://read.qxmd.com/read/38622477/muc16-can-predict-the-pregnancy-outcomes-in-human-and-intraperitoneal-administration-of-muc16-can-rescue-pregnancy-losses-in-mouse-models
#10
JOURNAL ARTICLE
Xiaona Huang, Huizhen Lin, Yue Zhao, Peixin Wang, Hanqi Ying, Songying Zhang, Liu Liu
Mucin 16 (MUC16) participates in the process of embryo implantation, but few studies have examined the association between MUC16 and pregnancy loss. To investigate this association, the expression of MUC16 in serum and decidua was compared between women with pregnancy loss and ongoing pregnancies. In vitro experiments and animal models were used to explore the role and underlying mechanisms of MUC16 in pregnancy loss. In human study, the expression of MUC16 in serum and decidua was both consistently lower in the women with pregnancy loss compared with those in women with ongoing pregnancies...
April 15, 2024: Reproductive Sciences
https://read.qxmd.com/read/38621927/-mechanism-of-bulleyaconitine-a-in-inhibiting-bone-destruction-of-rheumatoid-arthritis-via-src-pi3k-akt-signaling-pathway
#11
JOURNAL ARTICLE
Feng-Yu Huang, Wan-Yi Guo, Pei-Ping Chen, Xin-Zhuo Zhang, Zhuo-Hang Li, He-Lan Huang, Na Lin, Xiao-Hui Su, Xiang-Ying Kong
Based on the sarcoma receptor coactivator(Src)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt) signaling pathway, the mechanism of action of bulleyaconitine A in the treatment of bone destruction of experimental rheumatoid arthritis(RA) was explored. Firstly, key targets of RA bone destruction were collected through GeneCards, PharmGKB, and OMIM databa-ses. Potential targets of bulleyaconitine A were collected using SwissTargetPrediction and PharmMapper databases. Next, intersection targets were obtained by the Venny 2...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621884/-mechanism-of-guizhi-gancao-decoction-against-myocardial-ischemia-reperfusion-injury-based-on-network-pharmacology-and-experimental-verification
#12
JOURNAL ARTICLE
Lian-Yu Li, Lin-Lin Chen, Ping Liu
This study employed network pharmacology to investigate the effect of Guizhi Gancao Decoction(GGD) on myocardial ischemia-reperfusion injury(MI/RI) in rats and decipher the underlying mechanism. Firstly, the chemical components and targets of GGD against MI/RI were searched against the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP), SwissTargetPrediction, and available articles. STRING and Cytoscape 3.7.2 were used to establish the protein-protein interaction(PPI) network for the common targets, and then Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analyses were carried out for the core targets...
February 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38617965/revealing-the-active-ingredients-and-mechanism-of-p-sibiricumm-in-non-small-cell-lung-cancer-based-on-uplc-q-tof-ms-ms-network-pharmacology-and-molecular-docking
#13
JOURNAL ARTICLE
Kaili Guo, Yu Jiang, Wei Qiao, Panpan Yuan, Miao Xue, Jiping Liu, Hao Wei, Bin Wang, Xingmei Zhu
The alcohol extraction of P. sibiricum has exhibited significant inhibitory effects on the production of free radicals and the proliferation of non-small-cell lung carcinoma (NSCLC) A549 cells. Despite the diverse components found in alcohol extraction of P. sibiricum and its multiple targets, the active components and associated targets remain largely unidentified. Hence, there is a need for additional investigation into the pharmacodynamic elements and mechanisms of action. This study aimed to analyze and identify the components responsible for the anti-tumor activity of alcohol extraction from P...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38614160/the-emerging-role-of-fatty-acid-binding-protein-7-fabp7-in-cancers
#14
REVIEW
William George Warren, Myles Osborn, Andy Yates, Saoirse E O'Sullivan
Fatty acid binding protein 7 (FABP7) is an intracellular protein involved in the uptake, transportation, metabolism, and storage of fatty acids (FAs). FABP7 is upregulated up to 20-fold in multiple cancers, usually correlated with poor prognosis. FABP7 silencing or pharmacological inhibition suggest FABP7 promotes cell growth, migration, invasion, colony and spheroid formation/increased size, lipid uptake, and lipid droplet formation. Xenograft studies show that suppression of FABP7 inhibits tumour formation and tumour growth, and improves host survival...
April 11, 2024: Drug Discovery Today
https://read.qxmd.com/read/38607364/proteogenomic-characterization-reveals-estrogen-signaling-as-a-target-for-never-smoker-lung-adenocarcinoma-patients-without-egfr-or-alk-alterations
#15
JOURNAL ARTICLE
Seung-Jin Park, Shinyeong Ju, Sung-Ho Goh, Byoung-Ha Yoon, Jong-Lyul Park, Jeong-Hwan Kim, Seonjeong Lee, Sang-Jin Lee, Yumi Kwon, Wonyeop Lee, Kyung Chan Park, Geon Kook Lee, Seog Yun Park, Sunshin Kim, Seon-Young Kim, Ji-Youn Han, Cheolju Lee
UNLABELLED: Never-smoker lung adenocarcinoma (NSLA) is prevalent in Asian populations, particularly in women. EGFR mutations and anaplastic lymphoma kinase (ALK) fusions are major genetic alterations observed in NSLA, and NSLA with these alterations have been well studied and can be treated with targeted therapies. To provide insights into the molecular profile of NSLA without EGFR and ALK alterations (NENA), we selected 141 NSLA tissues and performed proteogenomic characterization, including whole genome sequencing (WGS), transcriptomic, methylation EPIC array, total proteomic, and phosphoproteomic analyses...
April 12, 2024: Cancer Research
https://read.qxmd.com/read/38605535/interaction-of-t-cell-specific-adapter-protein-with-src-and-tec-family-kinases
#16
JOURNAL ARTICLE
Zsuzsa Huszenicza, Brian C Gilmour, Lise Koll, Hanna Kjelstrup, Hanna Chan, Vibeke Sundvold, Stine Granum, Anne Spurkland
Adapter proteins are flexible and dynamic modulators of cellular signalling that are important for immune cell function. One of these, the T-cell-specific adapter protein (TSAd), interacts with the non-receptor tyrosine kinases Src and Lck of the Src family kinases (SFKs) and Itk of the Tec family kinases (TFKs). Three tyrosine residues in the TSAd C-terminus are phosphorylated by Lck and serve as docking sites for the Src homology 2 (SH2) domains of Src and Lck. The TSAd proline-rich region (PRR) binds to the Src homology 3 (SH3) domains found in Lck, Src and Itk...
May 2024: Scandinavian Journal of Immunology
https://read.qxmd.com/read/38602352/bosutinib-stimulates-macrophage-survival-phagocytosis-and-intracellular-killing-of-bacteria
#17
JOURNAL ARTICLE
Ronni A G da Silva, Claudia J Stocks, Guangan Hu, Kimberly A Kline, Jianzhu Chen
Host-acting compounds are emerging as potential alternatives to combating antibiotic resistance. Here, we show that bosutinib, an FDA-approved chemotherapeutic for treating chronic myelogenous leukemia, does not possess any antibiotic activity but enhances macrophage responses to bacterial infection. In vitro, bosutinib stimulates murine and human macrophages to kill bacteria more effectively. In a murine wound infection with vancomycin-resistant Enterococcus faecalis , a single intraperitoneal bosutinib injection or multiple topical applications on the wound reduce the bacterial load by approximately 10-fold, which is abolished by macrophage depletion...
April 11, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38594505/fak-linc01089-negative-regulatory-loop-controls-chemoresistance-and-progression-of-small-cell-lung-cancer
#18
JOURNAL ARTICLE
Xianteng Wang, Xingkai Li, Liman Niu, Fang Lv, Ting Guo, Yushun Gao, Yuliang Ran, Weiren Huang, Bing Wang
The focal adhesion kinase (FAK) tyrosine kinase is activated and upregulated in multiple cancer types including small cell lung cancer (SCLC). However, FAK inhibitors have shown limited efficacy in clinical trials for cancer treatment. With the aim of identifying potential therapeutic strategies to inhibit FAK for cancer treatment, we investigated long non-coding RNAs (lncRNAs) that potentially regulate FAK in SCLC. In this study, we identified a long non-coding RNA LINC01089 that binds and inhibits FAK phosphorylation (activation)...
April 9, 2024: Oncogene
https://read.qxmd.com/read/38591778/effects-of-syndecan-4-silencing-on-the-extracellular-matrix-remodeling-in-anoikis-resistant-endothelial-cells
#19
JOURNAL ARTICLE
Jessica Oyie Sousa Onyeisi, Helena Bonciani Nader, Carla Cristina Lopes
Anoikis is a process of programmed cell death induced by the loss of cell/matrix interactions. In previous work, we have shown that the acquisition of anoikis resistance upregulates syndecan-4 (SDC4) expression in endothelial cells. In addition, SDC4 gene silencing by microRNA interference reverses the transformed phenotype of anoikis-resistant endothelial cells. Due to this role of SDC4 in regulating the behavior of anoikis-resistant endothelial cells, we have evaluated that the functional consequences of SDC4 silencing in the extracellular matrix (ECM) remodeling in anoikis-resistant rabbit aortic endothelial cells submitted to SDC4 gene silencing (miR-Syn4-Adh-1-EC)...
April 9, 2024: Cell Biology International
https://read.qxmd.com/read/38589675/pdia2-has-a-dual-function-in-promoting-androgen-deprivation-therapy-induced-venous-thrombosis-events-and-castrate-resistant-prostate-cancer-progression
#20
JOURNAL ARTICLE
Yinan Li, Lei Lv, Meng Ye, Ning Xie, Ladan Fazli, Yuli Wang, Weilun Wang, Shuofei Yang, Qihong Ni, Jiaquan Chen, Xiangjiang Guo, Yiping Zhao, Guanhua Xue, Jianjun Sha, Xuesen Dong, Lan Zhang
Androgen deprivation therapy (ADT) is the first line of treatment for metastatic prostate cancer (PCa) that effectively delays the tumor progression. However, it also increases the risk of venous thrombosis event (VTE) in patients, a leading cause of mortality. How a pro-thrombotic cascade is induced by ADT remains poorly understood. Here, we report that protein disulfide isomerase A2 (PDIA2) is upregulated in PCa cells to promote VTE formation and enhance PCa cells resistant to ADT. Using various in vitro and in vivo models, we demonstrated a dual function of PDIA2 that enhances tumor-mediated pro-coagulation activity via tumor-derived extracellular vehicles (EVs)...
April 8, 2024: Oncogene
keyword
keyword
59610
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.